Construction of non-viral (synthetic) DNA vectors has been a major focus in gene therapy research in recent years. Several novel formulations of synthetic vectors have been developed in the applicant's laboratory including pH-sensitive immunoliposomes, DC-chol cationic liposomes, lipopolylysine, liposome/polylysine/DNA ternary complexes (LPDI), etc. Recently, the applicant developed a novel targetable DNA vector which consists of a polycation-condensed DNA core and an anionic lipid coating (LPDII). Preliminary data show that negatively charged LPDIIs are compact (70-80 nm in diameter) non-aggregating particles which can be conjugated to a targeting ligand for highly efficient and tissue-specific transfection in cultured breast cancer cells. The high-affinity receptor for folate (Kd approximately 1 nm) has recently been identified as a marker for a variety of human tumors including breast carcinomas and is found to be absent in most normal tissues. Folate was chosen as the targeting ligand for tissue-specific delivery to breast cancer due to its small size, stability, and possible lack of in vivo immunogenicity. There are three main objectives for the proposed study. First, a folate-targeted LPDII vector will be optimized for reporter gene delivery in vitro. MDA231 cells, a breast cancer cell line overexpressing the folate receptor, and a plasmid carrying the luciferase reporter gene will be used. Factors such as polylysine-chain length, lipid composition and the incorporation of a fusogenic and/or nuclear localization signal peptide on the transfection activity and other vector properties will be examined. Secondly, the folate-targeted LPDII will be optimized for tissue-specific gene transfer in vivo. Biodistribution and tissue-specific expression of the reporter genes will be examined in normal mice and nude mice carrying xenographic implants derived from MDA231 cells following intravenous injection of the vector. The effect of lipid composition and PEG-coating on the plasma stability, specificity and the transfection efficiency of the vector will be examined. Finally, the applicant will co-administer intravenously a plasmid carrying the herpes simplex thymidine kinase (HS-TK) gene in the optimized tumor-specific LPDII vector and the antiviral drug ganciclovir into the tumor-carrying animals. Treatment protocols will be varied to achieve maximum tumor suppression. These studies should allow the applicant to critically evaluate the potential for the use of folate-targeted LPDII vectors in tumor-specific gene transfer and the gene therapy treatment of human breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA071731-03S1
Application #
2869659
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Program Officer
Wolpert, Mary K
Project Start
1996-07-12
Project End
2000-06-30
Budget Start
1998-07-09
Budget End
2000-06-30
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lui, V W; He, Y; Huang, L (2001) Specific down-regulation of HER-2/neu mediated by a chimeric U6 hammerhead ribozyme results in growth inhibition of human ovarian carcinoma. Mol Ther 3:169-77
Li, S; Huang, L (2000) Nonviral gene therapy: promises and challenges. Gene Ther 7:31-4
Li, S; Tan, Y; Viroonchatapan, E et al. (2000) Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am J Physiol Lung Cell Mol Physiol 278:L504-11
Whitmore, M; Li, S; Huang, L (1999) LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 6:1867-75
Li, S; Wu, S P; Whitmore, M et al. (1999) Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol 276:L796-804
Nikitin, A Y; Juarez-Perez, M I; Li, S et al. (1999) RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice. Proc Natl Acad Sci U S A 96:3916-21
Tan, Y; Li, S; Pitt, B R et al. (1999) The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 10:2153-61
Brisson, M; He, Y; Li, S et al. (1999) A novel T7 RNA polymerase autogene for efficient cytoplasmic expression of target genes. Gene Ther 6:263-70
Yang, J P; Huang, L (1998) Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene Ther 5:380-7
He, Y K; Lui, V W; Baar, J et al. (1998) Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor. Gene Ther 5:1462-71

Showing the most recent 10 out of 14 publications